The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors.

Butler, J; Hamo, CE; Filippatos, G; Pocock, SJ; Bernstein, RA; Brueckmann, M; Cheung, AK; George, JT; Green, JB; Januzzi, JL; +19 more... Kaul, S; Lam, CSP; Lip, GYH; Marx, N; McCullough, PA; Mehta, CR; Ponikowski, P; Rosenstock, J; Sattar, N; Salsali, A; Scirica, BM; Shah, SJ; Tsutsui, H; Verma, S; Wanner, C; Woerle, HJ; Zannad, F; Anker, SD; EMPEROR Trials Program; (2017) The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors. European journal of heart failure. ISSN 1388-9842 DOI: https://doi.org/10.1002/ejhf.933

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1002/ejhf.933

Abstract

Share

Download

Filename: The-Potential-Role-and-Rationale-for-Treatment-of-Heart-Failure-with-SGLT2-Inhibitors.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar